It seems like every week we are going to be talking about AI. This week did not have a $10 billion round go to an AI startup, but $300 million is...
Health, Wellness & Biotech
In 2022, companies that took the SPAC route to market performed so badly they were practically a punchline, but they鈥檙e making a comeback in 2023.
The new year did not start slowly, as U.S.-based startups saw five rounds of more than $200 million.
We take a look at five noteworthy rounds from the start of the year, with funding going to startups ranging from genetically modified trees to to a...
More unicorn companies left The 91精品 91精品 in December than joined. In the final month of 2022, three companies joined the board whilst...
Artificial intelligence is certainly having a moment right now. This week it was all about OpenAI with its massive $10 billion round.
Venture giant New Enterprise Associates announced Thursday it has closed on approximately $6.2 billion across two funds.
In 2022, over $900 million was poured into the pharmacy startup space in an attempt to turn a profit in an area of health care that makes...
As the venture market significantly slowed, Tiger Global also quietly decelerated dealmaking in the latter half of 2022.
After a strong start to the year, this week slowed down. No round came close to $200 million, and only three rounds hit the $100 million mark. Health...
In the past few years, investment in psychedelic startups has mostly focused on drug development in anticipation of FDA approval. But Oregon has...


67.1K Followers